Insights

Medibank (ASX:MPL) share price forecast for more growth: fund manager

The Aussie insurance sector is “experiencing some of the best conditions” in years
The post Medibank (ASX:MPL) share price forecast for more growth: fund manager appeared first on The Motley Fool Australia. –

The Medibank Private Ltd (ASX: MPL) share price has handily outperformed the S&P/ASX 200 Index (ASX: XJO) in 2021, despite a strong showing from the index.

Year-to-date, Medibank shares are up 14% compared to a 10.5% gain posted by the ASX 200.

And the integrated healthcare company could have more outperformance to come.

That’s according to Andrew Martin, the principal portfolio manager of the Alphinity Australian Share Fund and the Alphinity Concentrated Australian Share Fund.

Earnings upgrades ahead?

One of the catalysts that could see the Medibank share price charge higher in the months ahead is the potential for earnings upgrades.

Speaking to the Motley Fool earlier in October, Martin explained:

We invest in what we call earnings leadership. Those are companies that are performing better than the market expects from an earnings perspective. Companies that are getting consistent earnings upgrades.

Alphinity concentrates on analysing individual stocks bottom up. But when it comes to the potential for earnings upgrades, Martin pointed to the Aussie insurance sector as one to keep an eye on:

One of the few sectors left getting earnings upgrades is insurance. It’s traditionally quite a volatile sector, because you can get big hits every now and again. But they’re experiencing some of the best conditions they’ve experienced since the early 2000s. A much better pricing environment coming through is helping grow the top line, and then you get this expansion in margin.

Which brings us to the Medibank share price.

When asked which ASX shares he believes have the potential to outperform, Martin had a few up his sleeve.

Among those, he said, “We quite like Medibank. It’s an insurance company, but health insurance, so a different kind of market.”

Martin said the business has “really been transforming itself since it listed”.

It’s taken some really strong leadership in terms of sorting out a number of issues in the market around claims and what was happening in terms of healthcare costs going up materially. They’ve worked with the industry to try to contain pricing and therefore grow the industry.

How has the Medibank share price been performing?

Medibank shares are up 27% over the past 12 months. By comparison, the ASX 200 has gained 18% over that same time.

Over the past month, the Medibank share price has struggled a bit, down 1% to the current $3.47 per share.

At the current share price, the company pays a trailing dividend yield of 3.6%, fully franked.

You can read the Motley Fool’s full interview with Alphinity’s Andrew Martin here.

The post Medibank (ASX:MPL) share price forecast for more growth: fund manager appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank right now?

Before you consider Medibank, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Can the Medibank (ASX:MPL) share price hit $3.80 by the end of 2021?

Medibank (ASX:MPL) share price lifts as staff vaccine mandate hits headlines

The most important catalyst for outperforming ASX shares: fund manager

3 ASX shares that everyone’s underestimating right now

Here’s why the Medibank (ASX:MPL) share price is up 12% in the last 3 months

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!